Subgroup analyses revealed that irisin levels were negatively correlated with AST in the control group and positively correlated with BMI and WC in all obese patients without NAFLD and with HDL-CH in obese NAFLD patients [36]. This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatotic liver disease.